Publications
CAR T Cells
G-Rex®10, G-Rex®100, G-Rex®24 Well Plate
Publication Date: August 13, 2024
Adding irradiated, pooled allogeneic donor PBMCs as feeder cells increased the output of piggyBac transposon-engineered CAR-T cells made from lymphopenic, chemotherapy-pretreated patients. Patient PBMCs were electroporated on a Neon device with CAR19 or CAR123 transposons at 10 μg/mL DNA, activated with TransAct and expanded with IL-4, IL-7 and IL-21. In 14-day small-scale runs, the feeder raised CAR19 yield 4.5-fold (B-NHL, n=8) and CAR123 yield 9.3-fold (AML, n=10), with little change in the percentage of CAR-positive cells and no loss of cytotoxicity or early-memory phenotype; all feeder-produced products had a vector copy number of 5 or less. In 21-day GMP large-scale runs from 150-20…
Publications
CAR T Cells
G-Rex®24 Well Plate
Publication Date: August 7, 2024
T cells engineered with a new EphA3-targeted chimeric antigen receptor killed EphA3-positive glioblastoma cells and cleared tumors in mouse models. The receptor was built from a novel monoclonal antibody, clone 3C3-1, which detected EphA3 in 35 of 49 glioblastoma biopsies. CAR T cells made from healthy donor blood lysed EphA3-positive U251 cells but not EphA3-negative U87 cells. In mice carrying intracranial U251 tumors, two intravenous infusions blocked tumor growth, and benefit lasted beyond 100 days. The cells also killed patient-derived glioblastoma cultures and neurospheres, and infiltrated patient-derived organoids, where they induced apoptosis in proportion to EphA3 levels.
Publications
NK Cells
G-Rex®100M, G-Rex®100M-CS, G-Rex®6 Well Plate
Publication Date: July 24, 2024
NK cells and CD147-targeted CAR-NK cells expanded in G-Rex® 100M bioreactors matched those grown in G-Rex® 6-well plates in expansion, purity and function. Fifty to sixty million PBMCs were co-cultured with irradiated 721.221-mIL21 feeder cells in 300 mL of medium with IL-2 and IL-15, and both open- and closed-system bioreactors gave fold expansion, NK purity, metabolic markers and receptor phenotypes comparable to the plate. Retroviral CD147-IL15-CAR transduction (70.4% versus 65.5% CAR-positive in one run) and killing of hepatocellular carcinoma cells were also similar. After 120 weeks of cryopreservation, 93.0% of thawed bioreactor-grown NK cells were live. In NSG mice bearing SK-Hep1…
Publications
Other
G-Rex®10, G-Rex®100
Publication Date: July 11, 2024
Porcine islets cultured for 2 days at high surface density on gas-permeable silicone rubber membrane bases kept their viability and potency, whereas the same density on non-permeable bases destroyed them. Islets from 30 porcine preparations were seeded at up to 4,000 DNA IE/cm², a 20-fold increase over the standard limit of 200 IE/cm² used in T-flask controls. Finite-element models predicted full oxygenation on the membrane but 95.3% anoxic culture volume on non-permeable bases. Across 1,001–4,000 DNA IE/cm², OCR/DNA relative to paired controls averaged 96% on the membrane (n = 24) but 58% without it (n = 13). Diabetes reversal in nude mice receiving 2,000 IE (or its DNA equivalent) was 8…
Publications
Other
G-Rex®10
Publication Date: June 20, 2024
A single-use polyacrylate film placed over a resonant sensor in a culture dish tracks cell growth continuously and without labels, because the film absorbs secreted metabolites such as terpenoids, softens, and shifts the sensor's resonant frequency. HeLa cells seeded at 60000 cells cm⁻² produced a shift of over 30 MHz across 4 days, compared with 1.4 MHz when sensing the cells' intrinsic permittivity in a G-Rex®10 vessel. Higher seeding densities gave larger and faster shifts, and the drug marimastat reduced the response in a dose-dependent way. Niclosamide added to HeLa culture stopped the frequency decrease within a minute, and K562, HEK293, Jurkat, CHO and E. coli cultures also produce…
Publications
Other
G-Rex®10
Publication Date: June 20, 2024
A resonant sensor coupled to a polyacrylate film that absorbs secreted metabolites can track cell growth continuously and non-destructively inside a closed culture vessel. Sensing cells through their intrinsic permittivity gave only a 1.4 MHz shift, whereas the polyacrylate-based SMART dish gave over 30 MHz during four days of HeLa culture, more than a 20-fold sensitivity gain. The film softens as metabolites containing hydroxyl and alkenyl groups, such as terpenoids, accumulate, changing local permittivity. Responses scaled with seeding density (17, 21 and 27 MHz at 30,000, 60,000 and 120,000 cells per cm²), tracked K562 growth, detected niclosamide and marimastat effects, and worked wit…
Publications
CAR T Cells
G-Rex®24 Well Plate
Publication Date: May 31, 2024
Human 3D ovarian cancer models of increasing complexity showed that CAR T-cell activity is shaped by both malignant-cell-intrinsic and extrinsic factors. MUC1 and TnMUC1 CAR T cells killed OvCAR3 high-grade serous ovarian cancer cells but not G164 cells, whose resistance involved impaired death receptor signaling; the cIAP1/2 inhibitor birinapant restored killing. Fibroblast-derived CCL2 activated CCR2/4-positive CAR T cells and enabled killing of G164 spheroids. In collagen gels, fibroblasts deposited dense TGFβ-dependent extracellular matrix that kept CAR T cells at the gel periphery, and the TGFβ receptor inhibitor SB431542 allowed penetration and cytotoxicity. In a vascularized microf…
Publications
TCR T Cells, TIL Cells
G-Rex®100, G-Rex®24 Well Plate, G-Rex®6 Well Plate
Publication Date: May 30, 2024
Stimulating tumor-infiltrating lymphocytes with neoantigen-loaded antigen-presenting cells, a method called NeoExpand, selectively expands neoantigen-reactive TILs and preserves stem-like memory features that conventional OKT3 rapid expansion depletes. Applied to 25 consecutive TIL samples from tumors with p53 or RAS mutations, NeoExpand identified 16 reactivities and 42 TCRs, versus 9 reactivities and 14 TCRs with conventional expansion. Rapid expansion gave higher total CD3+ fold-expansion, but NeoExpand gave greater fold-expansion of neoantigen-reactive cells across the tested samples. Single-cell RNA sequencing showed that reactive cells included a stem-like memory cluster expressing…
Publications
CAR T Cells
G-Rex®24 Well Plate
Publication Date: May 29, 2024
Simultaneous CRISPR/Cas9 knockout of TRAC and B2M removed TCR and HLA-I from more than 80% of anti-CD19 CAR T cells without impairing their antitumor function; indels covered roughly 85% of TRAC and 93% of B2M alleles. RNA-seq analysed with the CRISPRroots pipeline flagged 9 critical potential off-targets for the B2M guide and 19 for the TRAC guide, yet Sanger sequencing with ICE found no indels at those sites, and three chromosomal translocations occurred at low frequencies, up to 1.5%, decreasing by day 20. Universal CAR T cells lysed Namalwa cells as efficiently as unedited CAR T cells across five tumor encounters while triggering less alloreactivity; sorted Tscm and Tcm products expan…
Publications
NK Cells
Publication Date: May 20, 2024
S309-CAR-NK cells reduced SARS-CoV-2 viral loads in the lungs of hACE2-NSG mice by roughly tenfold compared with vehicle. Primary NK cells from eight PBMC donors were transduced with an SFG vector encoding S309 scFv, a CD28 transmembrane domain, CD28, 4-1BB and CD3 zeta signaling domains and secreted IL-15, giving about 90% NK purity and 70% CAR expression. The CAR-NK cells bound pseudotyped Delta and Mu spike and recombinant Omicron spike protein, competitively blocked pseudovirus binding to 293T-hACE2 cells, and lysed A549 cells expressing Delta, Mu and Omicron spike more efficiently than S2E12-CAR-NK cells. Mice received 1 x 10^5 PFU intranasally and three intravenous doses of 5 x 10^6…
Publications
CAR T Cells
G-Rex®6 Well Plate
Publication Date: May 14, 2024
Adding Toll-like receptor 4 signaling domains to a second-generation CD19 CAR improved tumor killing and cytokine release without tonic activity. MyD88, TLR4 and TRIF constructs were first screened in Jurkat cells, then carried into lentiviral vectors and transduced into primary human T cells at a mean efficiency of 51%, expanded for 7 to 10 days in G-Rex® six-well plates. Against Raji lymphoma cells the TLR4 construct lysed targets significantly better than the 4-1BB benchmark, while CD19-negative lines triggered no activation. In a subcutaneous MDA-MB-231-hCD19 breast tumor model treated peritumorally with 2.5 × 10^6 cells, serum interferon-gamma one day later was highest in the TLR4 gr…
Publications
NKT Cells
G-Rex®6M Well Plate
Publication Date: May 14, 2024
A feeder-free, serum-free, five-stage culture of about six weeks differentiates gene-engineered cord-blood CD34+ hematopoietic stem and progenitor cells into IL-15-enhanced allogeneic CAR-NKT cells, with more than a 10^6-fold expansion from input HSPCs to mature cells. Cells were generated from 15 cord-blood donors with CARs against BCMA, CD19, GD2, GPC3 and EGFRvIII. In a mouse multiple myeloma xenograft model, a single dose of 10 × 10^6 BCMA-CAR cells with IL-15 eliminated tumor in nine of ten mice and all experimental mice survived beyond 80 days, whereas BCAR-T-treated mice died of tumor growth and GvHD. The cells selectively depleted tumor-associated macrophages and MDSCs, which expr…
No manuscripts match your filters.